Tata India Pharma & Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹224 Cr | ₹1310 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | Nifty Pharma TRI |
| Turn Over | % | 26.49% |
| Expense Ratio | 2.35 | 2.14 |
| Manager | Rohan Korde | Meeta Shetty |
| ISIN Code | INF00XX01BL5 | INF277K016A9 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | -5.63% | -4.56% |
| 6 Month | -13.17% | -9.08% |
| 1 Year | -7.25% | -2.18% |
| 3 Year | 16.49% | 20.41% |
| 5 Year | - | 14.5% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | -9.06% | -6.87% |
| 1 Year | -16.17% | -8.62% |
| 3 Year | 7% | 11.19% |
| 5 Year | - | 13.84% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 17.33% | 7.74% |
| 3 Year | 19.38% | 18.94% |
| 5 Year | - | 15.54% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | 14.52% | 14.23% |
| Sharp | 0.82% | 0.98% |
| Beta | 0.9% | 0.92% |
| Alpha | -1.59% | 1.32% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Rohan Korde | Meeta Shetty |
| Total AUM | ₹4626 Cr | ₹17847 Cr |
| Funds Managed | 10 | 5 |
| ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 5.53 | 2.84 |
| Large Cap | 30.13 | 19.92 |
| Mid Cap | 37.01 | 40.02 |
| Small Cap | 27.33 | 37.23 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 2.11 | 1.31 |
| Healthcare | 93.05 | 95 |
| Industrials | 1.04 | - |
| Financial Services | 1.35 | - |
| Basic Materials | 2.46 | 3.68 |
Top Comparisons
Tata Gilt Securities Fund -Regular Plan- Growth Option
3Y Returns6.58%
Edelweiss Government Securities Fund - Regular Plan - Growth Option
3Y Returns6.33%
Bandhan Financial Services Fund - Regular (G)
3Y Returns0%
LIC MF Banking & Financial Services Fund Regular-Growth
3Y Returns13.88%
Kotak Medium Term Fund - Growth
3Y Returns7.99%
Invesco India Medium Duration Fund - Regular - Growth
3Y Returns6.76%
Nippon India Nifty 50 Value 20 Index Fund - Regular Plan - Growth Option
3Y Returns13.43%
UTI Nifty Next 50 Index Fund - Regular Plan - Growth Option
3Y Returns20.39%